Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial

Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial

Objective: To compare the efficacy and safety of a novel thermochemotherapy scheme and the instillation of pirarubicin (THP) without hyperthermia in patients with intermediate- and high-risk nonmuscle-invasive bladder cancer (NMIBC). Materials and methods: Between June 2012 and December 2016, 300 pa...

Full description

Bibliographic Details
Main Authors:	Jun Zhou, Linlin Li, Xing Li, Qian Yu, Shaowei Cui, Kunpeng Shu, Jianjun Liu, Jie Liu, Degang Ding, Tao Du
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-01-01
Series:	International Journal of Hyperthermia
Subjects:	nonmuscle-invasive bladder cancer (nmibc) pirarubicin (thp) hyperthermia intravesical chemotherapy thermochemotherapy
Online Access:	http://dx.doi.org/10.1080/02656736.2019.1646929

Similar Items

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
by: Qiang Ruan, et al.
Published: (2021-02-01)

Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
by: Hongwei Shi, et al.
Published: (2021-10-01)

Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2023-12-01)

Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
by: Hongwei Shi, et al.
Published: (2021-11-01)

Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies
by: Shintaro Yanazume, et al.
Published: (2022-05-01)

Urinary Tumor DNA-Based Diagnosis and Surveillance for Nonmuscle-Invasive Bladder Cancer—Current Landscape and Future Directions
by: Alexander Shiang, et al.
Published: (2023-07-01)

Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin
by: Kenji Tsukigawa, et al.
Published: (2020-12-01)

Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer
by: Jiawei Shi, et al.
Published: (2019-11-01)

In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
by: Gang Chen, et al.
Published: (2012-08-01)

Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors
by: Atsushi Makimoto, et al.
Published: (2021-07-01)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
by: Mei Peng, et al.
Published: (2019-10-01)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
by: Tian-Wei Wang, et al.
Published: (2019-10-01)

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis
by: Shiro Saito, et al.
Published: (2020-09-01)

Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
by: Lin PT, et al.
Published: (2022-11-01)

Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways
by: Yang Zhang, et al.
Published: (2023-01-01)

Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report
by: Yutaka Kato, et al.
Published: (2023-05-01)

Nonmuscle myosin IIA dynamically guides regulatory light chain phosphorylation and assembly of nonmuscle myosin IIB
by: Kai Weißenbruch, et al.
Published: (2022-04-01)

Nonmuscle Myosin II is Required for Larval Shell Formation in a Patellogastropod
by: Xinyu Liu, et al.
Published: (2022-02-01)

Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
by: Po-Ting Lin, et al.
Published: (2023-02-01)

Role of second transurethral resection in determining residual tumor in nonmuscle-invasive bladder cancer
by: Pukar Maskey, et al.
Published: (2017-12-01)

Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney
by: Karla L. Otterpohl, et al.
Published: (2017-12-01)

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review
by: Fouad Nahhat, et al.
Published: (2022-09-01)

Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study
by: Noboru Sasaki, et al.
Published: (2022-03-01)

Nonmuscle myosin IIA is involved in recruitment of apical junction components through activation of α-catenin
by: Masayuki Ozawa
Published: (2018-05-01)

Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients
by: Radosław Piliszek, et al.
Published: (2022-06-01)

Novel Therapeutic Strategies for BCG-unresponsive Non-muscle Invasive Bladder Cancer
by: Peng Zhang, et al.
Published: (2022-12-01)

Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study protocol for a randomized, controlled pilot and feasibility study
by: Sarah P. Psutka, et al.
Published: (2022-12-01)

Isoquercitrin alleviates pirarubicin-induced cardiotoxicity in vivo and in vitro by inhibiting apoptosis through Phlpp1/AKT/Bcl-2 signaling pathway
by: Lei Wang, et al.
Published: (2024-03-01)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2021-01-01)

Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer
by: Zhenyu Nie, et al.
Published: (2023-04-01)

Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model
by: Ying Xu, et al.
Published: (2024-12-01)

Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients
by: Wenhao Zhou, et al.
Published: (2020-03-01)

Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia
by: Chamodi Pillippu Hewa, et al.
Published: (2024-02-01)

Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China
by: Peng Guo, et al.
Published: (2022-01-01)

Authors′ Reply
by: Gyanendra R. Sharma, et al.
Published: (2015-01-01)

Treatment options in non-muscle-invasive bladder cancer after BCG failure
by: Nathan A Brooks, et al.
Published: (2015-01-01)

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
by: Shouki N Bazarbashi, et al.
Published: (2016-01-01)

Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study
by: Dai Koguchi, et al.
Published: (2020-12-01)

Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer
by: Piyush K Agarwal, et al.
Published: (2008-01-01)